Nobivac DHPPi
Nobivac DHPPi
Authorised
- Canine parainfluenza virus, strain Cornell, Live
- Canine parvovirus, strain 154, Live
- Canine adenovirus 2, strain Manhattan LPV3, Live
- Canine distemper virus, strain Onderstepoort, Live
Product identification
Medicine name:
Nobivac DHPPi
Active substance:
- Canine parainfluenza virus, strain Cornell, Live
- Canine parvovirus, strain 154, Live
- Canine adenovirus 2, strain Manhattan LPV3, Live
- Canine distemper virus, strain Onderstepoort, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parainfluenza virus, strain Cornell, Live316228.00/50% tissue culture infectious dose1.00millilitre(s)
-
Canine parvovirus, strain 154, Live10000000.00/50% tissue culture infectious dose1.00millilitre(s)
-
Canine adenovirus 2, strain Manhattan LPV3, Live10000.00/50% tissue culture infectious dose1.00millilitre(s)
-
Canine distemper virus, strain Onderstepoort, Live10000.00/50% tissue culture infectious dose1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate for solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Clear, glass (Type I Ph.Eur) vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cartons or plastic box with 10 single dose vials of vaccine lyophilisate
- Clear, glass (Type I Ph.Eur) vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cartons or plastic box with 50 single dose vials of vaccine lyophilisate
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10996/166/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 11/05/2025
How useful was this page?:
